Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 3
1949 1
1950 3
1951 5
1952 5
1953 3
1954 1
1955 7
1956 5
1957 3
1958 8
1959 7
1960 5
1961 6
1962 3
1963 12
1964 4
1965 6
1966 25
1967 18
1968 10
1969 10
1970 13
1971 11
1972 11
1973 11
1974 10
1975 21
1976 24
1977 19
1978 32
1979 26
1980 24
1981 20
1982 15
1983 29
1984 17
1985 26
1986 38
1987 33
1988 37
1989 40
1990 36
1991 25
1992 24
1993 28
1994 45
1995 34
1996 47
1997 39
1998 48
1999 39
2000 51
2001 47
2002 65
2003 70
2004 73
2005 68
2006 85
2007 81
2008 72
2009 92
2010 74
2011 73
2012 87
2013 129
2014 140
2015 148
2016 170
2017 144
2018 147
2019 140
2020 73
Text availability
Article attribute
Article type
Publication date

Search Results

2,776 results
Results by year
Filters applied: . Clear all
Page 1
The role of hormones in the pathogenesis of psoriasis vulgaris.
Roman II, Constantin AM, Marina ME, Orasan RI. Roman II, et al. Clujul Med. 2016;89(1):11-8. doi: 10.15386/cjmed-505. Epub 2016 Jan 15. Clujul Med. 2016. PMID: 27004020 Free PMC article. Review.
Psoriasis vulgaris is a chronic, common skin disease, which affects the patient's quality of life to the highest degree. Several exogenous factors and endogenous hormonal changes may act as triggers for psoriasis. ...A number of conditions are associated with
Psoriasis vulgaris is a chronic, common skin disease, which affects the patient's quality of life to the highest degree. Sever
Efficacy of biologic therapies in psoriasis vulgaris.
Mala R, Fida M, Jorgaqi E, Vasili E. Mala R, et al. Dermatol Ther. 2019 Jul;32(4):e12936. doi: 10.1111/dth.12936. Epub 2019 Apr 25. Dermatol Ther. 2019. PMID: 30983095
Psoriasis is a chronic, immune-mediated skin disease that also has systemic manifestations. Biologic preparates: Adalimumab, Etanercept, and Infliximab are licensed for psoriasis vulgaris treatment in Albania. ...In the study took place 78 patient diagnosed w
Psoriasis is a chronic, immune-mediated skin disease that also has systemic manifestations. Biologic preparates: Adalimumab, Etanerce
Psychological and Sexual Consequences of Psoriasis Vulgaris on Patients and Their Partners.
Alariny AF, Farid CI, Elweshahi HM, Abbood SS. Alariny AF, et al. J Sex Med. 2019 Dec;16(12):1900-1911. doi: 10.1016/j.jsxm.2019.08.017. Epub 2019 Sep 18. J Sex Med. 2019. PMID: 31542353
AIM: To evaluate the psychopathological and sexual aspects of psoriasis vulgaris in patients and their partners compared to healthy controls. ...Psychological and Sexual Consequences of Psoriasis Vulgaris on Patients and Their Partners. J Sex Med 2019; …
AIM: To evaluate the psychopathological and sexual aspects of psoriasis vulgaris in patients and their partners compared to he …
Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis.
Zhang CS, May B, Yan Y, Yu JJ, Yao D, Chang S, Zhang AL, Guo X, Lu C, Xue CC. Zhang CS, et al. Complement Ther Med. 2016 Apr;25:55-60. doi: 10.1016/j.ctim.2015.12.014. Epub 2016 Jan 11. Complement Ther Med. 2016. PMID: 27062949 Review.
Search results were entered in a spreadsheet, citations that were consistent with psoriasis vulgaris were identified based on: (i) a description of the features of psoriasis vulgaris and (ii) judgment by two clinicians regarding relevance to psorias
Search results were entered in a spreadsheet, citations that were consistent with psoriasis vulgaris were identified based on: …
Identification of psoriasis vulgaris biomarkers in human plasma by non-targeted metabolomics based on UPLC-Q-TOF/MS.
Li SS, Liu Y, Li H, Wang LP, Xue LF, Yin GS, Wu XS. Li SS, et al. Eur Rev Med Pharmacol Sci. 2019 May;23(9):3940-3950. doi: 10.26355/eurrev_201905_17823. Eur Rev Med Pharmacol Sci. 2019. PMID: 31115022 Free article.
CONCLUSIONS: The data suggest that psoriasis vulgaris patients may have disrupted lipid and amino acid metabolism, as well as inflammation and functional lesions in the liver and kidney. This study deepens the understanding of psoriasis vulgaris pathog …
CONCLUSIONS: The data suggest that psoriasis vulgaris patients may have disrupted lipid and amino acid metabolism, as well as …
Multicomponent Biomarker Approach Improves the Accuracy of Diagnostic Biomarkers for Psoriasis Vulgaris.
Reimann E, Lättekivi F, Keermann M, Abram K, Kõks S, Kingo K, Fazeli A. Reimann E, et al. Acta Derm Venereol. 2019 Dec 1;99(13):1258-1265. doi: 10.2340/00015555-3337. Acta Derm Venereol. 2019. PMID: 31612239 Free article.
Accurate biomarker-based diagnosis of psoriasis vulgaris has remained a challenge; no reliable disease-specific biomarkers have yet been identified. ...Both literature-based and data-driven selection of biomarker was conducted to select candidates for a multicompone …
Accurate biomarker-based diagnosis of psoriasis vulgaris has remained a challenge; no reliable disease-specific biomarkers hav …
Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy.
Abu El-Hamd M, Adam El Taieb M, Mahmoud AA, Mahmoud Samy O. Abu El-Hamd M, et al. J Dermatolog Treat. 2019 Sep;30(6):545-548. doi: 10.1080/09546634.2018.1543848. Epub 2018 Nov 28. J Dermatolog Treat. 2019. PMID: 30482111
This study included 30 patients with psoriasis vulgaris and 20 healthy individuals. Psoriasis Area and Severity Index (PASI) score were used to evaluate the patients with psoriasis vulgaris before and after treatment. ...Results: The serum level …
This study included 30 patients with psoriasis vulgaris and 20 healthy individuals. Psoriasis Area and Severity Index ( …
Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
Yan R, Jiang S, Wu Y, Gao XH, Chen HD. Yan R, et al. Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):135-44. doi: 10.4103/0378-6323.175919. Indian J Dermatol Venereol Leprol. 2016. PMID: 26924402 Free article. Review.
Topical calcipotriol/betamethasone dipropionate ointment/gel has been commonly used for the treatment of psoriasis vulgaris. ...We aimed to assess the effects and safety profile of calcipotriol/betamethasone dipropionate for the treatment of psoriasis vulg
Topical calcipotriol/betamethasone dipropionate ointment/gel has been commonly used for the treatment of psoriasis vulgaris. . …
Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Question-naire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris.
Ständer S, Steinke S, Augustin M, Metze D, Loser K, Baeumer D, Sieder C, Luger T. Ständer S, et al. Acta Derm Venereol. 2019 Nov 1;99(12):1085-1090. doi: 10.2340/00015555-3275. Acta Derm Venereol. 2019. PMID: 31386163 Free article. Clinical Trial.
Chronic pruritus is a bothersome symptom in psoriasis vulgaris and can profoundly reduce quality of life (QoL). In this exploratory analysis of the PSORITUS study, the impact of pruritus on QoL in 130 subjects with moderate-to-severe psoriasis was assessed us …
Chronic pruritus is a bothersome symptom in psoriasis vulgaris and can profoundly reduce quality of life (QoL). In this explor …
Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials.
Yu JJ, Zhang CS, Coyle ME, Du Y, Zhang AL, Guo X, Xue CC, Lu C. Yu JJ, et al. Curr Med Res Opin. 2017 Feb;33(2):279-287. doi: 10.1080/03007995.2016.1254605. Epub 2016 Nov 10. Curr Med Res Opin. 2017. PMID: 27786567 Review.
OBJECTIVE: This review aims to evaluate the efficacy and safety of compound glycyrrhizin in combination with conventional therapy for psoriasis vulgaris. ...Randomized controlled trials comparing compound glycyrrhizin plus conventional therapy to conventional therap …
OBJECTIVE: This review aims to evaluate the efficacy and safety of compound glycyrrhizin in combination with conventional therapy for pso
2,776 results
Jump to page
Feedback